Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gds Regulatory News (SMSD)

Share Price Information for Samsung El.gds (SMSD)

Share Price is delayed by 15 minutes
Get Live Data
3,530.00    -205.00 (-5.49%)
Bid:
3,525.00
Ask:
3,545.00
Spread: 20.00 (0.567%)
Market Cap: $927.20b
SMSD Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gds Share Chart

  • This share is an international stock.

Charitable Contribution

30 Apr 2025 08:45

RNS Number : 8065G
Samsung Electronics Co. Ld
30 April 2025
 

Charitable Contribution

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("SEC") on April 30, 2025, announced that its Board of Directors has authorized the following contributions.

 

Contributions for a fund to provide performance incentives to suppliers for SEC's Device Solutions ("DS") Division

- SEC will provide approximately KRW 38.6 billion for incentives to be distributed to qualified

 suppliers from the 181 first- and second-tier suppliers for the DS Division that are classified as

 SMEs and are stationed within the operations.

- The incentives aim to contribute to preventing worksite accidents, improving product quality, and

 expanding activities that encourage mutual cooperation with SEC's partners.

- Evaluations of supplier performances in the first half of 2025 will be conducted in August 2025; and evaluations for the second half of 2025 will be conducted in February 2026.

- Suppliers scoring above a certain rating will receive incentive payments from an available total of

 the estimated KRW 38.6 billion, which estimation is subject to change depending on evaluation

 results and management outcome of DS Division.

- SEC will contribute to "Large, Small-and-Medium Size Enterprises, Farming and Fishing Industries

 Cooperation Foundation," which will distribute the incentive to the eligible suppliers.

- The total estimated amount to be provided to all suppliers stationed within the DS Division

 operations is KRW 49.8 billion.

 

 

Donations to the Korean Red Cross to support the regions affected by the wildfires in Gyeongsang province and Ulsan

- SEC will have donated a total of KRW 1.85 billion in May 2025 to Korean Red Cross, which includes KRW 0.9 billion donated in March 28, 2025, to support the recovery of damaged areas in Gyeongsang province and Ulsan.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPKKBQOBKKNQN
12
Date   Source Headline
1st Jun 20268:51 amRNSCorporate Governance Report FY2025
29th May 20269:45 amRNS2026 1Q Interim Business Report
30th Apr 20269:03 amRNS2025 Business Report
30th Apr 20268:51 amRNSTransaction with Affiliate Company
30th Apr 20267:49 amRNSQuarterly Dividend for First Quarter 2026
30th Apr 20267:47 amRNS2026 1Q Earnings Release
24th Apr 20269:30 amRNSReport on Share Repurchase Results
7th Apr 20268:31 amRNSNotice of 1Q 2026 Earnings Release Schedule
7th Apr 20268:31 amRNS1Q 2026 Pre-Earnings Guidance
31st Mar 20268:32 amRNSDecision on Cancellation of Shares
25th Mar 20268:28 amRNSReport on Share Disposition Results
19th Mar 20267:46 amRNSSamsung Electronics Corporate Value Enhancement
18th Mar 20268:38 amRNSCharitable Contribution
18th Mar 20268:28 amRNSDecision on Share Disposition
18th Mar 20268:28 amRNSDecision on Share Repurchase
18th Mar 20268:28 amRNSResults of the 57th Annual General Meeting
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:47 amRNSReport on Share Repurchase Results
12th Mar 20267:47 amRNSReport on Share Repurchase Results
25th Feb 20267:00 amRNSReplacement of Reference Material for 2026 AGM
13th Feb 20267:44 amRNSCharitable Contributions
13th Feb 20267:43 amRNSReference Material for 2026 AMG
12th Feb 202610:04 amRNS2025 Consolidated Financial Statements
12th Feb 202610:03 amRNS2025 Separate Financial Statements
4th Feb 20268:50 amRNSReport on Share Disposition Results
29th Jan 20268:25 amRNSReport on Share Disposition Results
29th Jan 20268:24 amRNSDecision on Share Disposition
29th Jan 20268:23 amRNSDecision on Share Repurchase
29th Jan 20267:52 amRNS2025 Capex Results
29th Jan 20267:52 amRNSYear-End Dividend for FY2025
29th Jan 20267:00 amRNS2025 4Q Earnings Release
27th Jan 20268:20 amRNSReport on Share Repurchase Results
26th Jan 20267:00 amRNSDecision on Share Disposition
8th Jan 20268:23 amRNSNotice of 4Q 2025 Earnings Release Schedule
8th Jan 20268:23 amRNS4Q 2025 Pre-Earnings Guidance
7th Jan 202610:28 amRNSDecision on Share Repurchase
28th Nov 20258:32 amRNS2025 3Q Interim Business Report
28th Nov 20258:29 amRNSTransaction with Affiliate Company
28th Nov 20258:27 amRNSAppointment of New Chief Executive Officer
28th Nov 20258:27 amRNSCharitable Contribution
5th Nov 20258:19 amRNSReport on Share Disposition Results
30th Oct 20258:16 amRNSDecision on Share Disposition
30th Oct 20257:58 amRNSCharitable Contribution
30th Oct 20257:58 amRNSAnnouncement of Capex Plan for FY 2025
30th Oct 20257:56 amRNSQuarterly Dividend for Third Quarter 2025
30th Oct 20257:00 amRNS2025 3Q Earnings Release
14th Oct 20258:44 amRNSNotice of 3Q 2025 Earnings Release Schedule
14th Oct 20258:42 amRNS3Q 2025 Pre-Earnings Guidance
2nd Oct 20259:02 amRNSReport on Share Repurchase Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.